functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />
The use of HBO in the acute closed head injury<br />
was studied in 1992 by Rockswold et al. when<br />
they r<strong>and</strong>omly selected for HBO treatment from<br />
168 patients who had a Glascow Coma Score of<br />
9 or less for at least 6 hours. HBOT did not<br />
increase the number of patients in the favorable<br />
outcome category. (6) It is now believed that<br />
there is a therapeutic window of between three<br />
<strong>and</strong> 6 hours for the treatment of TBI with<br />
HBOT(7), although delayed multiple HBO<br />
treatment may be beneficial.(8)<br />
HBO can protect the nervous system by improving<br />
brain metabolism, decreasing intracranial pressures,<br />
blunting the inflammatory response, improving the<br />
integrity of the blood brain barrier <strong>and</strong> reducing<br />
edema, <strong>and</strong> mitigating apoptosis.(9) HBOT was<br />
found to improve cerebral blood flow, as<br />
determined by SPECT scan, in a study of 50<br />
patients with chronic brain injury (10) An<br />
improvement in aerobic brain metabolism was seen<br />
in 37 severely brain injured patients after they<br />
underwent up to seven one-hour treatments<br />
with HBOT. These authors demonstrated a<br />
reduction in cerebrospinal fluid lactate, a reduction<br />
in intracranial pressure, <strong>and</strong> an increased cerebral<br />
metabolic rate.(11) None of these studies looked<br />
at clinical outcomes.<br />
Longhi et al. reported later that there was no<br />
evidence of a clinical benefit of hyperoxia<br />
for head injury, demonstrating that the ratio<br />
between lactate <strong>and</strong> pyruvate, which they<br />
deemed a better indicator of brain metabolism,<br />
was unchanged after hyperoxia (not<br />
HBOT).(12)<br />
In a review of the literature, McDonagh et al.<br />
reported in 2004 that the clinical significance of<br />
HBOT on <strong>functional</strong> status was ‚unclear,‛ but that<br />
the evidence did support a small decrease in<br />
overall mortality.(13) Shi et al., however,<br />
concluded that HBO therapy had ‚specific curative<br />
effects‛ after studying the use of HBO therapy<br />
in320 patients post-brain injury. They measured<br />
the recovery of clinical symptoms, control of<br />
epilepsy, <strong>and</strong> resolution of hydrocephalus. SPECT<br />
imaging was performed before <strong>and</strong> after treatment<br />
to assess the therapeutic effects of HBOT. These<br />
147<br />
authors concluded HBO therapy was superior to<br />
medications alone <strong>and</strong> that SPECT imaging could<br />
be used to demonstrate those individuals with<br />
neurological dysfunction that may<br />
be amenable to HBO treatment.(14)<br />
HBOT has been used as an adjunct to radiationinduced<br />
necrosis of the brain which demonstrates<br />
its potential neuroprotective role.(15) The use of<br />
HBOT for bony injuries <strong>and</strong> soft tissue radiation<br />
injury was recommeded by Feldmeirer after a<br />
review of 74 studies in the literature. He further<br />
noted that there was increasing evidence in<br />
support of HBOT for radiation-induced brain<br />
necrosis.(16)<br />
Treatment frequency of HBOT has been found to<br />
be a factor in improving neuropsychiatric effects of<br />
chronic brain injury <strong>and</strong> this may occur via<br />
enhanced mitochondrial recovery. This benefit is<br />
proposed when HBO treatment is used at lower<br />
pressures <strong>and</strong> greater frequency. Many reports<br />
describe the use of ‚mild‛ hyperbaric oxygen<br />
therapy at pressures of 1.5 atmospheres or less<br />
<strong>and</strong> ongoing treatments.(17)<br />
This was illustrated by a pilot case study of a<br />
54-year-old male who had sustained a TBI one<br />
year previous, causing permanent neurological<br />
symptoms. Electrophysiological, behavioral, <strong>and</strong><br />
metabolic measures were obtained to evaluate the<br />
impact of HBOT on his neurocognitive function.<br />
After the first series of 20 treatments, the authors<br />
noted improvements in motor <strong>and</strong> sensory<br />
measures. These were paralleled by<br />
electrophysiological measures. The improvements<br />
were not sustained at one year. He then received<br />
a second series of 60 HBO treatments one year<br />
later.(18)<br />
Notable aspects of this case study are the<br />
documented measurable clinical improvements<br />
coincident with enhanced electrophysiological testing<br />
(P300 brainwave amplitude); however, there was<br />
no concomitant improvement in SPECT imaging<br />
seen.<br />
This may indicate that SPECT imaging is not the<br />
appropriate surrogate test to validate <strong>functional</strong><br />
2012